-
Loading metrics
Correction: Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer
- The PLOS ONE Staff
x
- Published: May 6, 2021
- https://doi.org/10.1371/journal.pone.0251671
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics